Posted by Michael Wonder on 15 Mar 2020
ICER posts draft scoping documents on bladder cancer and digital apps for opioid use disorder
13 March 2020 - Documents open to public comment until 2 April 2020.
The Institute for Clinical and Economic Review (ICER) has posted two Draft Scoping Documents for: bladder cancer and digital apps for opioid use disorder.
The draft scoping document for treatments of bladder cancer outlines the planned review of the comparative clinical effectiveness and value of nadofaragene firadenovec (Instiladrin, FKD Therapies Oy and Ferring Pharmaceuticals). The draft scoping document for digital apps used for opioid use disorder outlines the planned review of the comparative clinical effectiveness and value of the reSET-O app (Pear Therapeutics).
